Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jörg P, Halter"'
Autor:
Caroline Arber, Gabriela Baerlocher, Yves Chalandon, Michael Daskalakis, Michel Duchosal, Martin Fehr, Sabine Gerull, Tayfun Güngör, Gayathri Nair, Thomas Pabst, Jakob R. Passweg, Barbara Piccolruaz, Christoph Renner, Axel Ruefer, Dominik Schneidawind, Georg Stüssi, Sacha Zeerleder, Jörg P. Halter
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 10 (2024)
No abstract available.
Externí odkaz:
https://doaj.org/article/1a08507158c34aa0be6c05c66d9e61ff
Autor:
Sarah Jungius, Franziska C. Adam, Kerstin Grosheintz, Michael Medinger, Andreas Buser, Jakob R. Passweg, Jörg P. Halter, Sara C. Meyer
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMyelofibrosis (MF) is a rare hematopoietic stem cell disorder progressing to bone marrow (BM) failure or blast phase. Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative therapy for a limited subset of pa
Externí odkaz:
https://doaj.org/article/ab130bbf154f40a89377d4418000d849
Autor:
Franziska C. Adam, Jakub Szybinski, Jörg P. Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R. Passweg, Ivo Touw, Julia E. Maxson, Sara C. Meyer
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 805-815 (2022)
Chronic neutrophilic leukemia (CNL) relates to mutational CSF3R activation with membrane proximal CSF3R mutations such as T618I as driver mutations, but the significance of truncating mutations is not clarified. In CNL, concomitant mutations promote
Externí odkaz:
https://doaj.org/article/7c6926b7e08c4f438dc34b200fa1a338
Autor:
Luca Valore, Till Junker, Eva Heilmann, Christine S. Zuern, Matthias Streif, Beatrice Drexler, Christian Arranto, Jörg P. Halter, Christoph T. Berger
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionVaccine-induced myocarditis is a rare complication of messenger RNA (mRNA) COVID-19 vaccines.Case presentationWe report a case of acute myopericarditis in a recipient of allogeneic hematopoietic cells following the first dose of the mRNA-
Externí odkaz:
https://doaj.org/article/03011313d1824b06a19ac766351c01a5
Autor:
Nicolas Fattinger, Jan A. Roth, Helen Baldomero, Daiana Stolz, Michael Medinger, Dominik Heim, Michael Tamm, Jörg P. Halter, Jakob R. Passweg, Martina Kleber
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e704 (2022)
Pretransplant risk scores such as the revised Pretransplant Assessment of Mortality (rPAM) score help to predict outcome of patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Since the rPAM has not been validated externally
Externí odkaz:
https://doaj.org/article/55051c2c8a8b4b52b16ab848842c78c3
Autor:
Nina Worel, Mahmoud Aljurf, Chloe Anthias, Andreas S Buser, Meghann Cody, Mirjam Fechter, Sebastian Galeano, Hildegard T Greinix, Annika M Kisch, Mickey B C Koh, Thilo Mengling, Grazia Nicoloso, Dietger Niederwieser, Michael A Pulsipher, Adriana Seber, Bronwen E Shaw, Heather E Stefanski, Galen E Switzer, Jeff Szer, Suzanna M van Walraven, Hung Yang, Jörg P Halter
Publikováno v:
The Lancet Haematology. 9:e605-e614
The contribution of related donors to the globally rising number of allogeneic haematopoietic stem cell transplantations (HSCT) remains increasingly important, particularly because of the growing use of haploidentical HSCT. Compared with the strict r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac56dfaf239520c4407e9472b364d3a
https://doi.org/10.1016/s2352-3026(22)00184-3
https://doi.org/10.1016/s2352-3026(22)00184-3
Autor:
Guacimara Ortega Sanchez, Frank Stenner, Stefan Dirnhofer, Jakob Passweg, Sabine Gerull, Jörg P. Halter, Alfred Zippelius, Heinz Läubli
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 4546 (2019)
Cancer immunotherapy with immune checkpoint inhibitors (ICIs) such as programmed death ligand-1 (PD-L1) blockers offers pronounced clinical benefit with durable responses and a manageable safety profile. Patients with a high risk of immune-related ad
Externí odkaz:
https://doaj.org/article/f5f4da1eac9d4308a4014910d0b20e43
Autor:
Jérémie Héritier, Michael Medinger, Dominik Heim, Helen Baldomero, Christian Arranto, Jörg P. Halter, Jakob R. Passweg, Martina Kleber
Publikováno v:
Bone Marrow Transplantation. 57:613-619
Cyclosporine A (CsA) is commonly used for Graft versus Host Disease (GvHD) prophylaxis at a recommended starting dose of 3 mg/kg/d: Evidence for the effect of different CsA starting doses on GvHD risk is limited. We therefore estimated the associatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a18ed2f107a10b9fd6e36b1ddd7e596
https://doi.org/10.1038/s41409-022-01598-6
https://doi.org/10.1038/s41409-022-01598-6
Autor:
Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0910 (2018)
In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland. As of 2016, after 20 years, information was available for 7899 patients who ha
Externí odkaz:
https://doaj.org/article/c36c8bd0307b48e194437f606e771da4
Publikováno v:
Bone Marrow Transplantation. 57:391-398
Hepatic sinusoidal obstruction syndrome (SOS)/veno-occlusive disease (VOD) is a complication after allogenic hematopoietic stem-cell transplantation (allo-HSCT) with high mortality. The purpose of this study was to assess the incidence and outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b81f3da58dfe54fa0069dc3de2104e2
https://doi.org/10.1038/s41409-021-01546-w
https://doi.org/10.1038/s41409-021-01546-w